The Dad Bod Isn’t Vanity. It’s Biology.

At some point in their 40s or 50s, a lot of men notice the same thing.

They haven't changed what they eat. They're still training. Nothing dramatic has shifted in their habits. And yet the body is different. The waist is thicker. The middle is softer. Recovery from the same workouts takes longer than it used to.

The internal explanation most men land on is some version of discipline failure. They're not trying hard enough. They're getting lazy. They've let themselves go.

That explanation is wrong — or at least, it's radically incomplete.

What is actually happening in many cases is a well-documented biological feedback loop involving testosterone, visceral fat, and an enzyme called aromatase. Understanding this loop doesn't just reframe the dad bod. It changes what a rational response to it looks like.

The connection between testosterone and body composition runs in both directions. This is the part most men — and many physicians — never fully explain.

Lower testosterone contributes to increased visceral fat accumulation.¹ Testosterone influences how the body partitions energy and stores fat, with lower levels associated with a shift toward abdominal fat deposition. This is documented in longitudinal data: as testosterone declines across midlife, visceral fat tends to increase — independent of total caloric intake.²

But the relationship doesn't stop there. Visceral fat — the fat stored around the abdominal organs, not the subcutaneous fat just under the skin — is metabolically active in ways that subcutaneous fat is not.³ It contains significant concentrations of aromatase, an enzyme that converts testosterone into estradiol.³

This means that as visceral fat increases, aromatase activity increases, which converts more testosterone to estradiol, which further suppresses testosterone production through the hypothalamic-pituitary-testicular feedback axis. Lower testosterone then drives more visceral fat accumulation — which drives more aromatase activity — which drives testosterone lower still.

This is a self-reinforcing loop. Not a character flaw. Not a discipline failure. A physiological feedback mechanism that operates independently of willpower.

Recognizing it as biology is not an excuse to do nothing. It is the first step toward doing the right things — which are meaningfully different from simply trying harder at the things that aren't working.

This distinction matters clinically and is worth being precise about.

Visceral fat is fat deposited within the abdominal cavity, surrounding organs including the liver, pancreas, and intestines. It differs from subcutaneous fat — the fat stored directly under the skin — in several important ways.

Visceral fat is more metabolically active. It releases inflammatory cytokines, contributes to insulin resistance, and — relevant to this discussion — contains higher concentrations of aromatase than subcutaneous fat deposits.³ A man who carries his excess weight primarily in the abdomen has a meaningfully different metabolic and hormonal picture than a man of similar total body weight who carries it elsewhere.

This is why waist circumference is considered a more clinically relevant metabolic risk marker than body weight or BMI alone.⁴ And it is why the abdominal fat accumulation that tends to accompany male hormonal decline is not simply a cosmetic issue — it is a metabolic and endocrine one.

One of the most important and underappreciated findings in this space is what happens to testosterone when visceral fat decreases.

A systematic review and meta-analysis examining the relationship between weight loss and testosterone in overweight and obese men found that testosterone levels increase proportionally with degree of weight loss.⁵ The relationship is consistent and dose-dependent: more fat loss produces more testosterone recovery. In men with obesity-associated functional hypogonadism — where low testosterone is driven primarily by metabolic factors rather than primary endocrine failure — weight loss can normalize testosterone without any hormonal intervention.⁵

This has significant clinical implications. It means that for a meaningful subset of men experiencing symptoms consistent with testosterone deficiency, metabolic intervention is not a complement to hormonal treatment — it is the primary intervention. And it means that evaluating metabolic health is a necessary part of any honest hormonal workup, not a secondary consideration.

Valter Longo is a USC gerontologist whose research has focused on the relationship between nutrient sensing, metabolic health, and aging. His published randomized controlled trial — the most rigorous evidence tier in this space — examined what happens when healthy adults undergo three monthly cycles of a five-day fasting-mimicking diet (FMD) protocol.⁶

The results were specific and worth stating precisely. Three monthly FMD cycles produced reductions in body weight, trunk fat, blood pressure, and IGF-1 levels in the study population.⁶ These are meaningful cardiometabolic markers. The trunk fat finding is directly relevant to the visceral fat and aromatase conversation — reducing trunk fat reduces the aromatase load driving testosterone suppression.

Several things this research does not show, and that should be stated clearly:

The FMD is not a testosterone therapy. It does not directly raise testosterone. The mechanism — to the extent one exists — is indirect: reducing visceral fat reduces aromatase activity, which may allow testosterone levels to recover toward baseline. That pathway is biologically plausible but was not the primary endpoint of the Longo trial.⁶

The FMD is not appropriate for everyone. The protocol involves significant caloric restriction over five consecutive days. It is contraindicated in men with low body weight, a history of eating disorders, diabetes requiring medication management, and several other conditions. Clinician clearance before attempting any fasting protocol is not optional — it is required.

One disclosure that transparency demands: Longo's research group has disclosed IP licensing and equity interests connected to L-Nutra, the company behind ProLon, the commercial product based on the FMD protocol.⁶ We are telling you this because you deserve to know. The RCT data is real and peer-reviewed regardless of that commercial relationship. But the conflict exists and should be part of how you evaluate the research.

For readers who want to explore a structured FMD protocol, ProLon is the commercial product built around the dietary specifications used in Longo's published RCT. It is the closest consumer-accessible equivalent to the research protocol. It is not a testosterone therapy. It is not appropriate for everyone — clinician clearance is recommended before attempting any fasting protocol, and the contraindications are real. If you are a candidate, this is the evidence-anchored option in the category.

Before any dietary intervention, and certainly before any hormonal one, resistance training deserves mention as one of the most evidence-supported tools for improving body composition and supporting testosterone in midlife men.

Resistance training increases lean mass, reduces visceral fat accumulation, and has direct effects on the hormonal environment — including acute testosterone responses to heavy compound movements.⁷ It is not a replacement for addressing underlying hormonal deficiency when that deficiency is genuine and confirmed. But it is a primary lever that many men underutilize in favor of cardiovascular exercise alone — which has different and less favorable effects on body composition and the hormonal profile.⁷

The combination of resistance training and metabolic intervention — whether dietary or structured fasting — represents the behavioral foundation that should precede any pharmacological conversation about testosterone.

The bidirectional loop between visceral fat and testosterone does not resolve itself with harder cardio and fewer calories. It responds to targeted interventions that address the metabolic picture directly.

That means resistance training prioritized over steady-state cardiovascular exercise as the primary training modality. It means addressing visceral fat specifically — not just total body weight. It means evaluating whether a structured dietary intervention is appropriate for your situation, and having that conversation with a physician who can evaluate contraindications. And it means getting labs that capture both the hormonal and metabolic picture together — because treating one without understanding the other produces incomplete results.

None of this is simple. But none of it is mysterious either. The biology is well-documented. The levers are identifiable. What's been missing is a clear explanation of how they connect.

That's what this article is designed to provide.

The free ManopauseMD guide covers the metabolism pillar in full — including the aromatase mechanism, the weight-testosterone research, and how to think about metabolic and hormonal health as a single integrated picture rather than two separate conversations. If you are also trying to understand whether your testosterone levels are accurate, Your Labs Are Normal. So Why Do You Feel Like This? explains what reference ranges actually measure. For the cognitive side of hormonal decline, Brain Fog at 50 Isn't Normal covers the mechanism in detail. And if you want to understand the sleep-testosterone connection that compounds the metabolic picture, The Sleep-Testosterone Connection is the right next read.

One more honest scenario deserves naming. Some men run every behavioral lever in this article — resistance training prioritized, diet addressed, sleep repaired — and the metabolic markers still will not move. That is not a failure of discipline. It is the point where the loop has been running long enough that behavioral intervention alone may not open it, and where physician supervision becomes the rational next step. The evidence for the pharmacological side of that conversation is covered in To GLP or Not to GLP?; a physician-supervised program option from our vetted affiliate registry is below.